首页> 外文OA文献 >The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status

【2h】

The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status

机译：IDEA（国际辅助化疗持续时间评估）合作：III期试验的前瞻性联合分析，研究针对III期结肠癌患者的FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月至6个月）方案的辅助治疗的持续时间的III期试验：试验设计与现状

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Thierry André; null null; Timothy Iveson; Roberto Labianca; Jeffrey A. Meyerhardt; Ioannis Souglakos; Takayuki Yoshino; James Paul; Alberto Sobrero; Julien Taieb; Anthony F. Shields; Atsushi Ohtsu; Axel Grothey; Daniel J. Sargent;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献

1. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [J] . Thierry André, Timothy Iveson, Roberto Labianca, Current Colorectal Cancer Reports . 2013,第3期

机译：IDEA（国际辅助化疗持续时间评估）合作：研究III期结肠癌患者用FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月和6个月）方案的辅助治疗持续时间的III期试验的前瞻性联合分析：试验设计与现状
2. The IDEA Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX Regimen for Patients with Stage III Colon Cancer: Current Status [J] . Jeffrey A. Meyerhardt MD MPH, Daniel Sargent PhD, James Paul BSc, Gastrointestinal Cancer Research . 2014,第4aSuppla1期

机译：IDEA合作：研究III期结肠癌患者辅助治疗与FOLFOX方案持续治疗的III期试验的前瞻性组合分析
3. Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial [J] . Andre Thierry, Vernerey Dewi, Mineur Laurent, Journal of Clinical Oncology . 2018,第15期

机译：三个与6个月的oxaliplatin辅助化疗为III阶段结肠癌患者：无病的生存结果来自随机，开放标签，佐剂国际持续时间评估（想法）法国，第三阶段试验
4. The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [O] . Thierry André, Timothy Iveson, Roberto Labianca, -1

机译：IDEA（国际辅助化疗持续时间评估）合作：III期试验的前瞻性联合分析研究针对III期结肠癌患者的FOLFOX（FOLFOX4或改良的FOLFOX6）或XELOX（3个月至6个月）方案的辅助治疗的持续时间的III期试验：试验设计与现状
5. Three- versus six-month adjuvant FOLFOX or CAPOX for high-risk stage II and stage III colon cancer patients: the efficacy results of Hellenic Oncology Research Group (HORG) participation to the International Duration Evaluation of Adjuvant Chemotherapy (IDEA) project [O] . J. Souglakos, I. Boukovinas, S. Kakolyris, 2019

机译：六个月的六个月佐剂Folfox或Capox用于高风险阶段II和III阶段结肠癌患者：Hellenic肿瘤研究组（Horg）参与佐剂化疗的国际持续时间评估（IDEA）项目的疗效结果

著录项

引文网络

相似文献

相关主题

期刊订阅